Shibata K, Matsuo H. 1989. Effect of supplementing low protein diets with the limiting amino acids on the excretion of N1-methylnicotinamide and its pyridones in rats. J Nutr 119:896–901.
Spies TD, Bean WB, Stone RE. 1938. The treatment of subclinical and classic pellagra. J Am Med Assoc 111:584–592.
Stern RH, Spence JD, Freeman DJ, Parbtani A. 1991. Tolerance to nicotinic acid flushing. Clin Pharmacol Ther 50:66–70.
Stierum RH, Vanherwijnen MH, Hageman GJ, Kleinjans JC. 1994. Increased poly (ADP-ribose) polymerase activity during repair of (+/-)-anti-benzo[a]pyrene diolepoxide-induced DNA damage in human peripheral blood lymphocytes in vitro. Carcinogenesis 15:745–751.
Vivian VM, Chaloupka MM, Reynolds MS. 1958. Some aspects of tryptophan metabolism in human subjects. 1. Nitrogen balances, blood pyridine nucleotides, and urinary excretion of N-methylnicotinamide and N-methyl-2-pyridone-5-carboxamide on a low-niacin diet. J Nutr 66:587–598.
Wertz AW, Lojkin ME, Bouchard BS, Derby MB. 1958. Tryptophan-niacin relationships in pregnancy. J Nutr 64:339–353.
Winter SL, Boyer JL. 1973. Hepatic toxicity from large doses of vitamin B3 (nicotinamide). N Engl J Med 289:1180–1182.